When you receive a non-small cell lung cancer (NSCLC) diagnosis, it’s not just a physical diagnosis. You also experience mental and emotional symptoms. For example, shortness of breath, fatigue, anxiety, and stress are common experiences that patients report during treatment. Many patients look for safe, supportive ways to feel more in control of their breathing […]

If you’re receiving treatment for non-small cell lung cancer (NSCLC), especially chemotherapy or immunotherapy, you may find yourself dealing with painful mouth sores. These aren’t just annoying, small canker sores. They’re a painful, but common, side effect known medically as oral mucositis. This side effect can make eating, drinking, talking, and swallowing uncomfortable or even […]

Researchers at Fox Chase Cancer Center are studying a newer radiation technique called pulsed low-dose rate (PLDR), and early findings suggest it may help people with non-small cell lung cancer (NSCLC) experience fewer side effects without reducing the effectiveness of treatment. PLDR doesn’t change how much radiation is given; rather, it changes how the radiation […]

We had the opportunity to host Dr. Catherine Meador, thoracic oncologist and physician–scientist at Massachusetts General Hospital, in a “Ask the Expert” webinar. In the discussion, she explains the key differences between non-small cell and small cell lung cancer and how these distinctions shape treatment options. Missed the webinar? Here’s a recap of some of […]

When you’re diagnosed with lung cancer, managing your health goes beyond the clinical treatments. Additional lifestyle factors, including nutrition, movement, and mental health, are key components to help you feel your best during this challenging time. For tips on how to navigate these areas, we spoke with leading experts Dr. Martin Dietrich, a medical oncologist […]

What lifestyle factors should you be incorporating into your treatment plan? In Chapter 3 of “Precision Minute,” Dr. Stephen V. Liu, Associate Professor of Medicine and Director of Thoracic Oncology at the Lombardi Comprehensive Cancer Center of Georgetown University, outlines some support strategies for patients with non-small cell lung cancer (NSCLC). Tune in as Dr. […]

In Chapter 2 of “Precision Minute,” Dr. Stephen V. Liu, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics at the Lombardi Comprehensive Cancer Center of Georgetown University provides an overview of what treatment plans look like if you have ROS1 non-small cell lung cancer or ALK-positive NSCLC.  https://vimeo.com/1105147369/96a50d65fd?ts=0&share=copy Learn more […]

  Dr. Stephen V. Liu, a thoracic oncologist at Georgetown University’s Lombardi Comprehensive Cancer Center, explains how targeted therapy is transforming the way care teams are treating non-small cell lung cancer (NSCLC).  Unlike traditional chemotherapy and radiation therapy, targeted therapies focus on specific genetic changes that drive cancer growth. In this recap from Chapter One […]

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy. https://youtu.be/eCSzbsON9iE We recently hosted a webinar called “Optimizing NSCLC Treatment with Biomarker Testing Insights”, featuring Dr. Jessica Lin of Mass General Cancer Center. In it, Dr. […]

What is Palliative Care for Lung Cancer? Palliative care, or supportive care, is a medical specialty that is focused on symptom management rather than curative effects.  This type of care can provide the medical, emotional, and practical support you may need when faced with a diagnosis like cancer. Palliative care is not the same as […]

Differences Between Immunotherapy vs Targeted Therapy for NSCLC After your care team completes an initial biopsy and biomarker testing on your non-small cell lung cancer (NSCLC) tumor, they will determine the most effective treatment options for you based on the pathology of your tumor, the stage of your cancer, and your overall health. Comprehensive biomarker […]

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy. We recently hosted a webinar called “Optimizing NSCLC Treatment with Biomarker Testing Insights”, featuring Dr. Jessica Lin of Mass General Cancer Center. In it, Dr. Lin […]